Publication | Closed Access

Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: A 12-week double-blind, placebo-controlled pilot study

ObesityOlanzapine-associated Weight GainPsychiatryPsychotic DisorderMedicinePsychopharmacologySchizophreniaSocial SciencesMetabolic DysfunctionPharmacologyPsychopathologyPlacebo-controlled Pilot Study